Skip to main content

Advertisement

Table 1 Characteristics of patients with methicillin-resistant Staphylococcus aureus eligible for decolonization between January 2006 and June 2010 (n = 442)

From: Efficacy of the decolonization of methicillin-resistant Staphylococcus aureus carriers in clinical practice

  Proportion of patients  
  Patients treated Patients not treated P
(n = 268) (n = 174)  
Sex Male 142 (53) 104 (60) .160
  Female 126 (47) 70 (40)  
Age, mean, years ± SD 69.09 ± 16.52 69 ± 17.26 .9
Length of hospital stay mean, years ± SD 48.54 ± 35.71 36.91 ± 32.99 <.001
Type of MRSA colonization    
 Nosocomial 107 (39.9) 88 (50) .04
Site of colonization    
 Nose 147 (55) 53 (26.5) <.001
 Throat 115 (43) 43 (25) <.001
 Perineum 116 (43) 39 (25) <.001
 Others 109 (41) 146 (84) <.001
 Wound 85 (31.7) 46 (26.4) .2
Number of colonized sites    
 Mean, no ± SD 1.8 ± 1 1.6 ± 0.94 .03
 ≥2sites 128 (47.8) 64 (36.8) .02
Comorbidity (underlying condition)    
 Immunosuppressive therapy 36 (13.4) 39 (52) .01
 Diabetes 71 (65) 38 (35) .26
 Urine catheter 14 (5.2) 6 (3.4) .48
 Dialysis 11 (4.1) 4 (2.3) .30
 CVC 9 (3.3) 10 (5.7) .22
 COPD 31 (11.5) 33 (18.9) .003
  1. Note: data are no (%) of patients